Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Structure (London, England : 1993)|April 11, 2008
Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complexJacky Chi Ki Ngo, Mingdong Huang, David A Roth, et al.
Vaccine|January 20, 2007
GRA1 protein vaccine confers better immune response compared to codon-optimized GRA1 DNA vaccineMert Döşkaya, Mina Kalantari-Dehaghi, Craig M Walsh, et al.
Lupus Science & Medicine|March 24, 2023
Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial dataDavid D'Cruz, Gina Eriksson, Yulia Green, et al.
Lupus Science & Medicine|February 11, 2021
Efficacy of belimumab in two serologically distinct high disease activity subgroups of patients with systemic lupus erythematosus: post-hoc analysis of data from the phase III programmeToni Maslen, Ian N Bruce, David D'Cruz, et al.
Modern Rheumatology|December 16, 2021
Long-term safety and efficacy of belimumab in Japanese patients with SLE: A 7-year open-label continuation studyYoshiya Tanaka, Paula Curtis, Kathleen DeRose, et al.
Nature Communications|January 31, 2013
Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53Christopher D Wassman, Roberta Baronio, Özlem Demir, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 7, 2018
Long-Term Safety and Efficacy of Belimumab in Patients With Systemic Lupus Erythematosus: A Continuation of a Seventy-Six-Week Phase III Parent Study in the United StatesRichard A Furie, Daniel J Wallace, Cynthia Aranow, et al.
Human Gene Therapy|December 9, 2004
Nitroprusside increases gene transfer associated with intracoronary delivery of adenovirusDavid M Roth, N Chin Lai, Mei Hua Gao, et al.
Annals of the Rheumatic Diseases|January 4, 2018
A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South KoreaFengchun Zhang, Sang-Cheol Bae, Damon Bass, et al.
Lupus Science & Medicine|August 29, 2022
Renal response at 2 years post biopsy to predict long-term renal survival in lupus nephritis: a retrospective analysis of the Hopkins Lupus CohortSelin Cooper Blenkinsopp, Qinggong Fu, Yulia Green, et al.
Pageof 9